Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan · Delayed Price · Currency is TWD 62.60
-0.20 (-0.32%)
At close: Sep 24, 2026
TPEX:7806 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 74.71 | 117.65 | 116.51 | 61.92 | 41.37 |
Cash & Short-Term Investments | 74.71 | 117.65 | 116.51 | 61.92 | 41.37 |
Cash Growth | 2.39% | 0.98% | 88.15% | 49.67% | - |
Accounts Receivable | 119.43 | 152.55 | 108.79 | 113.23 | 35.01 |
Other Receivables | 0.9 | 0.15 | 2.36 | 4.33 | 3.75 |
Receivables | 120.32 | 152.7 | 111.15 | 117.57 | 38.75 |
Inventory | 95.29 | 89.39 | 82.21 | 69.08 | 52.63 |
Other Current Assets | 93.49 | 85.2 | 9.02 | 3.05 | 2.34 |
Total Current Assets | 383.81 | 444.95 | 318.89 | 251.61 | 135.1 |
Property, Plant & Equipment | 700.34 | 632.33 | 416.65 | 319.46 | 108.34 |
Other Intangible Assets | 7.33 | 8.37 | 9.12 | 6.22 | 0.94 |
Long-Term Deferred Tax Assets | 2.71 | 2.36 | 1.34 | 0.99 | - |
Other Long-Term Assets | 26.75 | 18.97 | 14.4 | 11.76 | 3.7 |
Total Assets | 1,121 | 1,107 | 760.4 | 590.03 | 248.08 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 35.09 | 27.89 | 32.72 | 44.74 | 21.28 |
Accrued Expenses | 19.65 | 22.18 | 21.92 | 21.55 | 4.85 |
Short-Term Debt | 24.5 | 44.5 | - | 86 | 50 |
Current Portion of Long-Term Debt | 63.62 | 17.51 | 26.35 | 14.83 | - |
Current Portion of Leases | 5.46 | 9.92 | 8.46 | 0.37 | 14.31 |
Current Income Taxes Payable | 15.21 | 20.63 | 6.95 | 20.95 | - |
Current Unearned Revenue | 0.75 | 11.46 | 4.51 | 2.94 | 1.41 |
Other Current Liabilities | 51.3 | 19.51 | 14.28 | 16.28 | 4.61 |
Total Current Liabilities | 215.58 | 173.59 | 115.18 | 207.65 | 96.46 |
Long-Term Debt | 127.19 | 153.29 | 163.84 | 126.05 | - |
Long-Term Leases | 3.58 | 5.92 | 9.13 | - | 11.93 |
Total Liabilities | 346.34 | 332.81 | 288.15 | 333.7 | 108.39 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 278.6 | 278.6 | 238.6 | 149 | 106.92 |
Additional Paid-In Capital | 357.76 | 357.76 | 147.3 | 20.69 | - |
Retained Earnings | 124.32 | 137.82 | 86.35 | 86.65 | 32.76 |
Shareholders' Equity | 774.6 | 774.18 | 472.25 | 256.33 | 139.68 |
Total Liabilities & Equity | 1,121 | 1,107 | 760.4 | 590.03 | 248.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 224.34 | 231.15 | 207.77 | 227.25 | 76.24 |
Net Cash (Debt) | -149.63 | -113.49 | -91.26 | -165.32 | -34.87 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -5.33 | -4.37 | -3.92 | -8.20 | -2.57 |
Filing Date Shares Outstanding | 29.25 | 29.25 | 25.05 | 21.9 | 13.55 |
Total Common Shares Outstanding | 29.25 | 29.25 | 25.05 | 21.9 | 13.55 |
Working Capital | 168.23 | 271.36 | 203.7 | 43.97 | 38.64 |
Book Value Per Share | 26.48 | 26.46 | 18.85 | 11.70 | 10.31 |
Tangible Book Value | 767.27 | 765.8 | 463.13 | 250.12 | 138.75 |
Tangible Book Value Per Share | 26.23 | 26.18 | 18.49 | 11.42 | 10.24 |
Land | 269.63 | 269.2 | 188.33 | 112.04 | - |
Buildings | 100.43 | 67.75 | 67.75 | 67.28 | - |
Machinery | 236.9 | 220.84 | 200.46 | 178.16 | 107.19 |
Construction In Progress | 188.44 | 148.29 | 5.53 | - | - |